Corrigendum

No authors listed

Published Erratum

No authors listed. Diabet Med. 2022 Apr.

. 2022 Apr;39(4):e14765.

doi: 10.1111/dme.14765. Epub 2022 Feb 20.

No abstract available

Erratum for

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.
Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, Feldman EL; DCCT/EDIC Research Group. Herman WH, et al. Diabet Med. 2012 Jul;29(7):937-44. doi: 10.1111/j.1464-5491.2012.03644.x. Diabet Med. 2012. PMID: 22417277 Free PMC article. Clinical Trial.

1. Herman WH, Pop-Busui R, Braffett BH, et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med. 2012;29:937-944. doi:10.1111/j.1464-5491.2012.03644.x